NCT04284189Recruiting
Aftercare of Childhood Cancer Survivors in Switzerland
Aftercare of Childhood Cancer Survivors in Switzerland - the ACCS Switzerland Project
Source: ClinicalTrials.gov · Last updated 17 Aug 2022 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The Aftercare of Childhood Cancer Survivors in Switzerland (ACCS) study is a multicenter cohort study designed to investigate transition of follow-up care from pediatric oncology to adult care in a prospective and longitudinal way. The investigators collect data on preferences and expectations for follow-up care and transition to adult care by questionnaires in adolescent and young adult survivors of childhood cancer.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 140 (estimated)
- First submitted
- 20 Feb 2020
- Start date
- 12 Feb 2019
- Primary completion date
- Apr 2025
- Lead sponsor
- Kantonsspital Aarau
- Diseases
- Childhood cancers
- NCT number
- NCT04284189
What you commit to
- Study type: Observational
- Planned participants: 140
- From 12 Feb 2019 to the primary completion date, Apr 2025
- 3 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Treatment only by means of surgery and without increased risk of late effects (e.g. teratoma)
Other illness
- Severe cognitive impairment, which makes it impossible to complete the questionnaire independently
Age
- \<5 years after therapy of a relapse or palliative situation
Other
- Insufficient knowledge of the German language
- Informed consent form not signed
Who the study is looking for
- 5-year survivor of childhood cancer
- Diagnosis according to ICCC3 I-XII; Langerhans cell histiocytosis (LCH), Hemophagocytic lymphohistiocytosis (HLH)
- Age at diagnosis \<18 years
- Age at study ≥16 years
- At study start in follow-up care at one of the three pediatric oncology centers (group before transition) or transitioned not before 2014 (group after transition).
- Written informed consent
Age in the registry: 16 years to - · Sex: All · Does not accept healthy volunteers
Sites (3)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Division of Oncology - Hematology, Department of Pediatrics, Kantonsspital Aarau Coordinator of this site? Confirm its status | Aarau | Switzerland | Recruiting |
| Division of Oncology/ Hematology, University Children's Hospital Basel Coordinator of this site? Confirm its status | Basel | Switzerland | Recruiting |
| Division of Oncology/ Hematology, Department of Pediatrics, Kantonsspital Lucerne Coordinator of this site? Confirm its status | Lucerne | Switzerland | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.